Related Experiment Videos
The no-effect level and optimal use of toxicity data.
1Department of Morbid Anatomy, London Hospital Medical College, United Kingdom.
Regulatory Toxicology and Pharmacology : RTP
|December 1, 1988
Summary
The term "no-observable-effect level" is preferred over "no-effect level" to acknowledge the difficulty in proving no effect. Understanding toxicological mechanisms and using safety factors with robust data are crucial for accurate risk assessment.
Area of Science:
- Toxicology
- Risk Assessment
- Pharmacokinetics
Background:
- Current terminology for effect levels in toxicology can be ambiguous.
- The distinction between no effect and no adverse effect is important for toxicological relevance.
- Accurate risk evaluation relies on understanding dose-response relationships and underlying mechanisms.
Purpose of the Study:
- To clarify the appropriate terminology for effect levels in toxicological studies.
- To emphasize the importance of toxicokinetic and metabolic data in justifying safety factors.
- To highlight the necessity of knowing the mechanism of action for reliable risk extrapolation.
Main Methods:
- Review and analysis of existing toxicological terminology.
- Discussion of the role of toxicokinetics and metabolism in safety factor determination.
- Emphasis on mechanistic understanding for risk assessment.
Main Results:
- "No-observable-effect level" (NOEL) is recommended over "no-effect level" to reflect scientific uncertainty.
- "No-adverse-effect level" (NAEL) is useful for distinguishing toxicologically relevant changes.
- Robust toxicokinetic and metabolic data are essential for scientifically justifying safety factors.
Conclusions:
- Precise terminology improves the clarity and accuracy of toxicological assessments.
- Mechanistic understanding is paramount for valid extrapolation and risk evaluation.
- The inclusion of recovery groups in long-term studies is advised for comprehensive data.